Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione announces that the consolidated sales volume for the fiscal year ended 31st March 2004 amounted to US$75m, representing a growth of 9% over the previous year.
Hovione and CyDex, today announced an alliance to develop and commercialize improved formulations of drugs that are off-patent or soon will be off-patent.
By Jorge Pastilha, Director of Logistics & Control and Filipe Gaspar, PhD, Process Engineer
To Mrs. Margot Wallström - Commissioner for the Environment, EU Commission, Brussels
Hovione is pleased to announce that it has installed a new state-of-the-art Spray Drying facility to address the latest technology in particle design.
Carla Vozone and Manuel Lourenço look at Simvastatin as a case study in the supply of off-patent API
Lab of the Year Submission
Google Chrome
Safari
Firefox
Edge